PUBLIC COMPANY
save$FATEFATE THERAPEUTICS INC
$FATESan Diego, CA, USupdated 3mo ago
community read0 votes
pipeline
8
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(8)
pipeline depth8 products
3Preclinical5Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- phase1FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- phase1FT819 in Subjects With B-cell Malignancies
- phase1A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- phase1FT576 in Subjects With Multiple Myeloma
- phase1FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- phase1FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
- phase1FT516 in Subjects With Advanced Hematologic Malignancies
🐶 Hiring Signal
News
- This week in charts: Brain drugs are back on venture capitalists’ mindsFive neurology-focused startups have together raised around $450 million in the last few weeks. Elsewhere, investors had a muted response to the latest cell therapy research.biopharma_dive · 7d ago
- Despite midterm losses, RFK Jr. is bullish on MAHA's futureRumors and speculation have swirled all year about the fate of HHS Secretary Robert F. Kennedy Jr., the political face of the Make America Healthy Again movement. But after a bruising midterm elect…endpoints · 10d ago
- Democrats’ midterm victory, and a questionable fertility procedureHow will the midterm results affect drug pricing policy? And why are women traveling to fertility clinics abroad? Find out on the new episode of "The Readout LOUD" podcast.stat · 14d ago
- STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drugShares of ProMis Neurosciences, developer of a treatment for Alzheimer’s disease, sold off sharply last week. A closer look at the reason why — and whether it holds up.stat · 15d ago
- STAT+: Where does MAHA go from here? 3 possible futuresRepublican losses leave Robert F. Kennedy Jr.’s MAHA movement with three possible futures.stat · 16d ago
- Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’Sanofi has discontinued an early-stage STAT6 degrader program licensed from Nurix Therapeutics, a decision analysts say is related to the asset itself or Sanofi’s strategic reprioritization rather…biospace · 16d ago
- STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHARFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.stat · 22d ago
- ‘The patient need is enormous’: Syntax programs stem cells into pancreatic beta cells in 4 daysChicago-based Syntax Bio believes it has cracked the code for turning stem cells into pancreatic beta cells in as little as four days.fiercebiotech · 24d ago
- From cells to organoids: Cytokines that shape 3D cultureHigh-quality cytokines for organoid growth, differentiation, and expansion.biospace · 1mo ago
- The Trump administration is doubling down on health care fraud investigationsAt the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.stat · 1mo ago
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that